Through immunoinformatics and virtual screening, the research focused on the identification of potential epitopes, which enabled the designing of a multi-epitope vaccine against brucellosis and the identification of potential drug candidates for the BvrR, OMP25, and OMP31 proteins in Brucella. The implementation of this strategy resulted in leading molecules that satisfied Lipinski's rule of five and also the right ADMET parameters. This evidence concerns the gene SYNJ2BP and brucellosis.